BXPHF:OTCMKTS
Botanix Pharmaceuticals Ltd
$0.0048
0.00%
(0.00) 1D
Nov 16, 9:30:01 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BXPHF...
Mkt. cap
22.10M
Avg. vol.
18.58K
Volume
0.00
52-wk high
$0.11
52-wk low
$0.00
Beta
9.94
Shares outstanding
2.76B
No. of employees
11
Mkt. cap
22.10M
Avg. vol.
18.58K
Volume
0.00
52-wk high
$0.11
52-wk low
$0.00
Beta
9.94
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
FOREX.com
·
13 minutes ago
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
·
8 hours ago
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
7 hours ago
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
5 hours ago
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com